Global immuno oncology assays market expected to generate around USD 6.63 billion by 2025, at a CAGR of around 12.9% between 2019 and 2025. The worldwide demand for immunology-based oncology assays is growing swiftly, owing to the increasing cancer prevalence, rising acceptance of targeted therapy, and growing demand for monoclonal antibodies (mAb).
The report covers a forecast and an analysis of the immuno oncology assays market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the immuno oncology assays market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the immuno oncology assays market on a global and regional level.
In order to give the users of this report a comprehensive view of the immuno oncology assays market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the immuno oncology assays market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the immuno oncology assays market on a global and regional basis.
The study provides a decisive view of the immuno oncology assays market by segmenting it based on product, assay, technology, indication, application, and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.
Some major players operating in the global immuno oncology assays market include Thermo Fisher Scientific, Agilent Technologies, Roche Diagnostics, Nanostring Technologies, Illumina, Foundation Medicine, Sartorius, Qiagen, HTG Molecular Diagnostics, PerkinElmer, and Merck.
Report Scope:
This report segments the global immuno oncology assays market into:
Global Immuno Oncology Assays Market: By Product
Global Immuno Oncology Assays Market: By Assay
Global Immuno Oncology Assays Market: By Technology
Global Immuno Oncology Assays Market: By Indication
Global Immuno Oncology Assays Market: By Application
Global Immuno Oncology Assays Market: By Region
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed